Ives Jeffrey L. - Insider Non-Derivative Transactions at Acumen Pharmaceuticals, Inc. (ABOS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 17, 2023, Ives Jeffrey L.'s relationship to Acumen Pharmaceuticals, Inc. (ABOS) is Director, and currently has 39,149 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ABOS insiders.
Data Source: SEC.
Ives Jeffrey L. - Insider Non-Derivative Transactions at ABOS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 18, 2023 | Sell -- (Common Stock) | 2800 | 6.66 | 0 |
| Aug 18, 2023 | Sell -- (Common Stock) | 39149 | 6.48 | 0 |
| Aug 18, 2023 | M -- (Common Stock) | 2800 | 1.19 | 2800 |
| Aug 18, 2023 | M -- (Common Stock) | 39149 | 0.72 | 39149 |